Obstetrician-gynecologists are disputing the safety of the abortion pill mifepristone as litigation on Food and Drug Administration approval makes its way through the courts.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.